Angel investor
Every published round Ken Loughnan took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Bodd | Unnamed stage | 3 Dec 2025 | $15m | Participant | Startup Daily (5 Dec 2025), SmartCompany, Startup Daily (3 Dec 2025) |
Companies Ken Loughnan has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Bodd | 3D body scanning platform | 3 Dec 2025 | 1 | 0 |
Fund closes reported for Ken Loughnan, as distinct from the investments it has made.
Companies Ken Loughnan has backed that another company then bought. An exit for the holding, not a deal Ken Loughnan did.
| Role | Organisation | Sources |
|---|---|---|
| No role recorded yet. Ken Loughnan has been mentioned, but not yet attached to an organisation. Know their role? | ||
Stories naming Ken Loughnan. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Six Australian startups, including Bodd, Hachiko and Cor, collectively secured about $24 million in fresh backing, while seaweed peer Sea Forest floated on the ASX and jumped in early trade.
Weekly funding roundup covering raises by Bodd, Hachiko, Fremantle Seaweed, Cor, Detail Earth and Recovr, plus seaweed peer Sea Forest's ASX float at a $112 million market capitalisation.
Also Startup Daily
Bodd has banked a $15 million round with Blue Sky Capital leading and Ellerston Capital among backers, funding global expansion and a health push; the deal values the body-scanning company at $110 million.